Yazarlar |
Mehmet Altunova
|
Recep Gulmez
|
Dr. Öğr. Üyesi Muammer KARAKAYALI
Kafkas Üniversitesi |
Ismail Gurbak
|
Omer Tasbulak
|
Gokhan Demirci
|
Arda Guler
|
Ali Evsen
|
Umit Bulut
|
Mehmet Erturk
|
Özet |
Critical limb ischemia (CLI) patients take too many medications because they are elderly and frail patients with multiple comorbidities. Polypharmacy is associated with frailty, although its prognostic significance in CLI patients is unknown. In this study, we aimed to determine the prevalence of hyperpolypharmacy among adults with CLI and its effect on 1-year amputation and mortality. |
Anahtar Kelimeler |
Hyperpolypharmacy,critical limb ischemia,endovascular therapy,major amputation,1-year mortality |
Makale Türü | Özgün Makale |
Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale |
Dergi Adı | VASCULAR |
Dergi ISSN | 1708-5381 |
Dergi Grubu | Q4 |
Makale Dili | İngilizce |
Basım Tarihi | 12-2023 |
Doi Numarası | 10.1177/17085381231193496 |